Cytoskeletal research
BPC-157 + TB-500
Research peptide blend
Account required· quoted per order
Size
| Molecular formula | C62H98N16O22 · C212H350N56O78S |
|---|---|
| Sequence | 15 aa · 43 aa |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC / MS) |
| Storage | −20 °C, protect from light |
| Use | Laboratory research only |
For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or cosmetic. No dosing, administration, or use guidance is provided.
About this compound
Identity & research context
A research blend of two synthetic peptides: BPC-157, a stable gastric pentadecapeptide (15 aa) derived from the human gastric-juice protein BPC, and TB-500, the full-length synthetic thymosin beta-4 polypeptide (43 aa) involved in G-actin sequestration and cytoskeletal dynamics. Both components have been studied in preclinical and in-vitro model systems for angiogenic signaling, nitric-oxide pathway modulation, and actin-mediated cell migration — with no approved human therapeutic indication.
Key research points
- Angiogenic & nitric-oxide pathway signaling (rodent / in-vitro)
- GI mucosal models, ischemia–reperfusion conditions
- G-actin sequestration & actin polymerization (in-vitro)
- Keratinocyte-migration & wound-model research (preclinical)
References
For research purposes only. Not FDA approved. Information shown is sourced from published peer-reviewed literature for educational reference only — not medical advice or product claims. Read the full disclaimer.
Also in the catalog
View all